Abstract
Pharmaceuticals and personal care products (PPCPs) in wastewater pose significant threats to both human health and aquatic ecosystems. Wastewater discharge from various sources is the primary cause of these contaminants, and proper treatment is essential for protecting the environment. Traditional treatment technologies are often too expensive and ineffective in removing PPCPs. Constructed wetlands (CWs) offer a sustainable, cost-efficient alternative for wastewater treatment, though their capability to eliminate PPCPs can vary based on multiple aspects. Recent studies highlight biochar-a carbon-rich material resultant from biomass pyrolysis-as a promising amendment to improve CW performance. However, there is a deficiency of proper literature reviews on using biochar in CWs specifically for PPCP removal. This review focuses on biochar's role in CWs and its effectiveness in removing PPCPs and enhancing microbial activity and nutrient cycling. A bibliometric analysis using Vosviewer software was used to assess the current research trends in the biochar-amended CWs to attenuate PPCPs. While biochar shows potential in eliminating PPCPs, challenges, such as optimizing its application and addressing long-term operational concerns for treating emerging pollutants like PPCPs. Future research should enhance biochar production and low-cost techniques for diverse groups of PPCPs and perform field trials to validate laboratory results under actual conditions exploring microbial-biochar and plant-biochar interactions. Addressing these challenges is crucial to advancing biochar-amended CWs and enhancing wastewater treatment on a global scale.